Sectorwise Visual Field Simulation Using Optical Coherence Tomographic Angiography Nerve Fiber Layer Plexus Measurements in Glaucoma.
Adult
Aged
Aged, 80 and over
Cross-Sectional Studies
Fluorescein Angiography
/ methods
Glaucoma
/ diagnostic imaging
Humans
Middle Aged
Models, Biological
Nerve Fibers
/ physiology
Prospective Studies
Retinal Ganglion Cells
/ physiology
Tomography, Optical Coherence
/ methods
Visual Field Tests
Visual Fields
/ physiology
Journal
American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
16
07
2019
revised:
14
11
2019
accepted:
14
11
2019
pubmed:
27
11
2019
medline:
10
5
2020
entrez:
27
11
2019
Statut:
ppublish
Résumé
To simulate 24-2 visual field (VF) using optical coherence tomographic angiography (OCTA) for glaucoma evaluation. Cross-sectional study. One eye each of 39 glaucoma and 31 age-matched normal participants was scanned using 4.5-mm OCTA scans centered on the disc. The peripapillary retinal nerve fiber layer plexus capillary density (NFLP-CD, %area) was measured. The NFLP-CD and 24-2 VF maps were divided into 8 corresponding sectors using an extension of Garway-Heath scheme. Sector NFLP-CD was transformed to a logarithmic dB scale and converted to sector simulated VF deviation maps. Comparing simulated and actual 24-2 VF maps, the worst sector was in the same or adjacent location in the same hemisphere 97% of the time. VF mean deviation (VF-MD) was simulated by NFLP mean deviation (NFLP-MD). The differences between NFLP-MD and VF-MD in early, moderate, and severe glaucoma stages were -0.9 ± 2.0, 0.9 ± 2.9, and 5.8 ± 3.2 dB. NFLP-MD had better (P = .015) between-visit reproducibility (0.63 dB pooled standard deviation) than VF-MD (1.03 dB). NFLP-MD had a significantly higher sensitivity than VF-MD (P < .001) and overall NFL thickness (P = .031). OCTA-based simulated VF agreed well with actual 24-2 VF in terms of both the location and severity of glaucoma damage, with the exception of severe glaucoma in which the simulation tended to underestimate severity. The NFLP-MD had better reproducibility than actual VF-MD and holds promise for improving glaucoma monitoring. The NFLP-MD had better diagnostic accuracy than both VF-MD and overall NFL thickness and may be useful for early glaucoma diagnosis.
Identifiants
pubmed: 31770516
pii: S0002-9394(19)30575-6
doi: 10.1016/j.ajo.2019.11.018
pmc: PMC7113124
mid: NIHMS1555286
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
57-68Subventions
Organisme : NEI NIH HHS
ID : P30 EY010572
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY010145
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY023285
Pays : United States
Organisme : NEI NIH HHS
ID : R21 EY027007
Pays : United States
Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.
Références
Opt Express. 2012 Feb 13;20(4):4710-25
pubmed: 22418228
Invest Ophthalmol Vis Sci. 2016 Aug 1;57(10):4485-92
pubmed: 27571015
Ophthalmology. 2003 Nov;110(11):2185-91
pubmed: 14597528
Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2654-9
pubmed: 12147599
Biomed Opt Express. 2015 Nov 02;6(12):4661-75
pubmed: 26713185
Ophthalmology. 2011 Feb;118(2):241-8.e1
pubmed: 20920824
Ophthalmology. 2014 Nov;121(11):2081-90
pubmed: 24974815
Am J Ophthalmol. 2019 Nov;207:99-109
pubmed: 31170389
Br J Ophthalmol. 2012 Jan;96(1):47-52
pubmed: 21478200
Invest Ophthalmol Vis Sci. 2013 Jun 21;54(6):4287-95
pubmed: 23716631
Biomed Opt Express. 2011 Apr 05;2(5):1097-105
pubmed: 21559122
Prog Retin Eye Res. 2007 Nov;26(6):688-710
pubmed: 17889587
Ophthalmology. 2017 Nov;124(11):1589-1599
pubmed: 28676279
JAMA Ophthalmol. 2015 Sep;133(9):1045-52
pubmed: 26203793
Invest Ophthalmol Vis Sci. 2006 May;47(5):2006-10
pubmed: 16639009
Am J Ophthalmol. 2017 Mar;175:37-44
pubmed: 27914978
Ophthalmology. 2018 Apr;125(4):578-587
pubmed: 29174012
Invest Ophthalmol Vis Sci. 1995 Jul;36(8):1658-64
pubmed: 7601645
Ophthalmology. 2002 Jun;109(6):1059-65
pubmed: 12045044
Opt Lett. 2015 May 15;40(10):2305-8
pubmed: 26393725
Ophthalmology. 2000 Oct;107(10):1809-15
pubmed: 11013178
Transl Vis Sci Technol. 2018 Feb 7;7(1):16
pubmed: 29430337
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT451-9
pubmed: 27409505
Ophthalmology. 2019 Jul;126(7):980-988
pubmed: 30858023
Invest Ophthalmol Vis Sci. 2014 Dec 09;56(1):259-71
pubmed: 25491294
Am J Ophthalmol. 2002 Oct;134(4):538-46
pubmed: 12383810
Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):3975-3985
pubmed: 28796875
Am J Ophthalmol. 2017 Dec;184:63-74
pubmed: 28964806
Ophthalmology. 2014 Jul;121(7):1322-32
pubmed: 24629312
PLoS One. 2017 Feb 2;12(2):e0170476
pubmed: 28152070
Ophthalmology. 2017 Jun;124(6):786-792
pubmed: 28268099
Invest Ophthalmol Vis Sci. 2011 Jul 01;52(7):4765-73
pubmed: 21467178
JAMA Ophthalmol. 2014 Mar;132(3):291-7
pubmed: 24407153
Am J Ophthalmol. 2016 Oct;170:41-49
pubmed: 27470061
Ophthalmology. 2016 Dec;123(12):2498-2508
pubmed: 27726964